Botulinum toxins in neurological disease (Q35759634)

10 August 2017

1 reference

title

Botulinum toxins in neurological disease (English)

1 reference

10 August 2017

Cynthia L Comella

1 reference

10 August 2017

Seth L Pullman

series ordinal

1 reference

10 August 2017

publication date

1 May 2004

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

628-644

1 reference

Long-term effect of botulinum toxin on impairment and functional health in cervical dystonia.

10 August 2017

cites work

1 reference

The DYT1 phenotype and guidelines for diagnostic testing

21 January 2018

1 reference

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

21 January 2018

1 reference

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.

21 January 2018

1 reference

Botulinum toxin type F for treatment of dystonia: long-term experience.

21 January 2018

1 reference

Long-term results and complications of botulinum A toxin in the treatment of blepharospasm

21 January 2018

1 reference

Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion

21 January 2018

1 reference

Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the "sausage poison".

21 January 2018

1 reference

Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis

21 January 2018

1 reference

Brachial plexopathy after botulinum toxin injections

21 January 2018

1 reference

Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis

21 January 2018

1 reference

Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response

21 January 2018

1 reference

Botulinum toxin treatment of tremors

21 January 2018

1 reference

Treatment of blepharospasm with botulinum toxin

21 January 2018

1 reference

Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia

21 January 2018

1 reference

Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin

21 January 2018

1 reference

Neuromuscular effects distant from the site of botulinum neurotoxin injection.

21 January 2018

1 reference

A radioimmuno-precipitation assay for antibodies to botulinum A.

21 January 2018

1 reference

Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients

21 January 2018

1 reference

Botulism in the United States: a clinical and epidemiologic review

21 January 2018

1 reference

Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Post-traumatic shoulder 'dystonia': persistent abnormal postures of the shoulder after minor trauma

21 January 2018

1 reference

Posttraumatic torticollis

21 January 2018

1 reference

Botulinum toxin therapy for limb dystonias

21 January 2018

1 reference

Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia

21 January 2018

1 reference

Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum)

21 January 2018

1 reference

Effects of repeated botulinum toxin injections on orbicularis oculi muscle

21 January 2018

1 reference

Antibodies to botulinum toxin

21 January 2018

1 reference

Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial

21 January 2018

1 reference

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia

21 January 2018

1 reference

Hand cramps: Clinical features and electromyographic patterns in a focal dystonia

21 January 2018

1 reference

Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance

21 January 2018

1 reference

Dysphagia after botulinum toxin injections for spasmodic torticollis: Clinical and radiologic findings

21 January 2018

1 reference

Localizing muscles for botulinum toxin treatment of focal hand dystonia

21 January 2018

1 reference

Posttraumatic cervical dystonia

21 January 2018

1 reference

Pathophysiologic aspects of human botulism

21 January 2018

1 reference

Botulinum toxin injections for essential voice tremor

21 January 2018

1 reference

Response and immunoresistance to botulinum toxin injections

21 January 2018

1 reference

Clinical Correlates of Response to Botulinum Toxin Injections

21 January 2018

1 reference

Long-term botulinum toxin treatment of focal hand dystonia

21 January 2018

1 reference

Management of cerebral palsy with botulinum-A toxin: preliminary investigation.

21 January 2018

1 reference

Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations.

21 January 2018

1 reference

Anticholinergics in adult-onset focal dystonia

21 January 2018

1 reference

The mechanism of action of tetanus and botulinum neurotoxins

21 January 2018

1 reference

Botulinum toxin treatment of essential head tremor

21 January 2018

1 reference

Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections

21 January 2018

1 reference

Modulation of parkinsonian tremor by radial nerve palsy

21 January 2018

1 reference

Usefulness of a writing device in writer's cramp

21 January 2018

1 reference

Botulinum toxin for blepharospasm: single-fiber EMG studies

21 January 2018

1 reference

Botulinum toxin: the story of its development for the treatment of human disease

21 January 2018

1 reference

Botulinum A toxin injection as a treatment for blepharospasm

21 January 2018

1 reference

Human response to botulinum toxin injection: Type B compared with type A

21 January 2018

1 reference

Brachial plexus neuropathy after botulinum toxin injection

21 January 2018

1 reference

Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Botulinum toxin in the treatment of writer's cramp: a double-blind study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.20033

1 reference

10 August 2017

1 reference